Matrix metalloproteinases (MMPs), a family of proteolytic enzymes which degrade the extracellular matrix, are implicated in blood-brain barrier disruption, which is a critical event leading to vasogenic edema. To investigate the role of reactive oxygen species (ROS) in the expression of MMPs in vasogenic edema, the authors measured gelatinase activities before and after cold injury (CI) using transgenic mice that overexpress superoxide dismutase-l . A marked induction of pro-gelatinase B (pro-MMP-9) was seen 2 hours after CI and was maximized at 12 hours in wild-type mice. The pro-MMP-9 level was significantly lower in transgenic mice 4 hours (P < 0.001) and 12 hours (P < 0.05) after CI compared to wild-type Matrix metalloproteinases ( MMPs) are known as a family of calcium-requiring, zinc-containing proteolytic enzymes, which degrade the extracellular matrix in a variety of physiologic and pathophysiologic conditions and play a crucial role in extracellular remodeling. They are secreted as inactive zymogens and require enzymatic cleavage of the N-terminus for activation ( Murphy, 1 995). Among MMPs, gelatinase A ( MMP-2) and gelati nase B ( MMP-9) are able to digest the endothelial basal lamina, which plays a major role in maintaining the in-Abbreviations used: AP-I, activator protein-I; BBB, blood-brain barrier; cr, cold injury; MMP, matrix metalloproteinase; MMP-2, gelatinase A; MMP-9, gelatinase B; MT-MMP-l, membrane type-l matrix metalloproteinase; ROS, reactive oxygen species; SDS, sodium dodecyl sulfate; SOD-I, superoxide dismutase-l; TIMP, tissue inhibi tor of metalloproteinase.
tegrity of the blood-brain barrier ( BBB). These MMPs are increasingly being implicated in the pathogenesis of several central nervous system diseases ( Yong et aI., 1 998), such as cerebral ischemia ( Rosenberg et aI. , 1 996, 1 998; Romanic et aI. , 1 998; Gasche et aI. , 1 999), mul tiple sclerosis ( Anthony et aI., 1 99 7), seizures ( Zhang et aI. , 1998) , bacterial meningitis ( Paul et aI. , 1 998) , and intracerebral hemorrhage ( Rosenberg and Navratil, 1 99 7) . These studies suggest the strong relationship be tween MMP activation and vasogenic edema formation though BBB disruption.
Va so genic edema is one of the most common f orms of brain edema observed in clinical practice, in which the functional integrity of the endothelial cells is altered, and permeability of brain capillary endo t helial cells to mac romolecules is increased by disruption of the tight junc tions that characterize the BBB ( Chan et aI. , 1 984 ). Cold injury ( CI) is well known as a classic model for vaso genic brain edema and trauma, in which increased BBB permeability and the pathogenesis that follows are well characterized ( Chan et aI. , 1 991) . In previous studies, increased BBB permeability was detected within 30 min-utes, lasted several hours to 3 to 4 days in the lesional and perilesional areas after CI, and was followed by for mation of the infarction ( Chan et aI., 198 7; Nag, 1996 ; Murakami et aI., 1999) . Furthermore, growing evidence suggests that oxygen radicals play an important role in the pathogenesis of lesions induced by CI ( Chan et aI., 19 91 ; Oury at aI., 199 3) .
In the present study, we sought to investigate the po tential role of MMPs on CI as a suitable and well characterized model for vasogenic edema. By zymo graphic measurement of gelatinase activity, we detected activation of MMP-9 with early induction of pro-MMP-9 and pro-MMP-2, which might be consistent with acute BBB disruption, and subsequent mild induction of pro MMP-2 and its activation 7 days after CI. To further investigate the role of reactive oxygen species ( R OS) on MMP induction and/or activation after CI, we examined the gelatinase activity in transgenic mice that overex p ress the endogenous antioxidant enzyme copper, zinc superoxide dismutase ( SOD-I) before and after CI. The results showed the inhibitory effects of SOD-I on both MMP induction and activation, suggesting the contribu tion of ROS to the formation of vasogenic edema by regulating MMP expression.
MATERIALS AND METHODS

Superoxide dismutase-l transgenic mice
Heterozygous SOD-l transgenic mice of the SOD-l TgHS/ SF-218-3 strain carrying human SOD-l genes were derived from the founder stock previously described (Epstein et aI., 1987) . They were bred on a CD-l mouse background. The SOD-l transgenic mice were identified by quantitative demon stration of SOD-l using nondenaturing gel electrophoresis fol lowed by nitroblue tetrazolium staining (Epstein et aI., 1987) . There were no observable phenotypic differences between SOD-l transgenic and wild-type normal littermates.
Cold injury and histologic assessment
SOD-l transgenic mice and wild-type normal littermates (male, 35 to 40 g, 3 months old) were subjected to CI according to the methods previously described (Chan et aI., 1991; Morita Fujimura et aI., 1999) . All procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by Stanford Universi ty's Administrative Panel on Laboratory Animal Care. Experi mental animals were anesthetized with chloral hydrate (350 mg/kg) and xylazine (4 mg/kg) intraperitoneally and placed in a stereotactic frame. The scalp was incised on the midline and the skull was exposed. A metal probe, 4 mm in diameter and cooled with dry ice, was applied to the surface of the skull with a 100-g weight for 30 seconds. The experimental animals were killed at 1, 2, 4, 6, 8, 12, and 24 hours and 3 and 7 days af ter CI.
Matrix metalloproteinase extraction
MMP extraction from brain tissue was performed as previ ously described, with minor modifications (Zhang and Gottschall, 1997) . Approximately 20 to 50 mg of damaged brain tissue and the homologous tissue from the contralateral cortex were cut into pieces 1 to 24 hours and 3 and 7 days after CI and were homogenized by douncing 15x in Teflon-glass tissue homogenizers (Wheaton, Millville, NJ, U.S.A.) in 10 vol of cold lysis buffer (basic buffer: 50 mmollL Tris-HCl [pH 7.6], 150 mmollL NaCl, 5 mmollL CaCI2, 0.05% BRIJ-35, 0.02% NaN3, containing 1 % Triton X-lOO). Five microliters of the homogenates were stored to measure the total amount of protein. The homogenates were then centrifuged at 4°C at 12,000 x g for 5 minutes. Fifty microliters of the supernatants were stored and used for Western blot analysis of tissue inhibi tor of metalloproteinase (TIMP) -I and TIMP-2, membrane type-l matrix metalloproteinase (MT -MMP-l), and l3-actin. The supernatants were also further incubated with a 1: 10 vol ume of gelatin sepharose 4B (Pharmacia Biotech AB, Uppsala, Sweden) for 1 hour at 4°C with constant shaking. After incu bation, samples were centrifuged at 500 x g for 2 minutes. Gel pellets were washed once with basic buffer. After centrifuga tion at 500 x g for 2 minutes, the pellets were resuspended in elution buffer (basic buffer containing 10% dimethylsulfoxide and 20% volume of lysis buffer). Purified samples were ana lyzed by zymography, type IV collagenolytic activity assay, and Western blotting. Protein concentrations were determined by the bicinchoninic acid method (BCA kit, Pierce, Rockford, IL, U.S.A.).
Zymography
Expression of the proform and activated form of MMP-2 and MMP-9 was analyzed by zymography (Kleiner and Stetler Stevenson, 1994) , which was performed according to the manufacturer's instructions (Novex, San Diego, CA, U.S.A.). One fifth volume of nonreducing sample buffer (004 mollL Tris, pH 6.8, 5% sodium dodecyl sulfate [SDS], 20% glycerol, 0.05% bromophenol blue) was added to the samples obtained as above and incubated for 10 minutes at room temperature. The samples were then loaded onto 10% SDS polyacrylamide gel electrophoresis gels containing 0.1 % gelatin (Novex). After running the gels, they were incubated with 2.5% Triton X-lOO two times for 20 minutes, equilibrated with I x developing buffer (Novex), and incubated for over 18 hours in the devel oping buffer at 37°C with gentle agitation. The gels were stained with coomassie blue (0.5% coomassie R-250, 30% methanol, 10% acetic acid) for 30 minutes and destained in washing solution (30% methanol, 10% acetic acid) as neces sary. White bands on a blue background indicated zones of digestion corresponding to the presence of different pro-MMPs and activated MMPs on the basis of their molecular weight. One tenth nanogram of human pro-MMP-9 and human pro MMP-2 (Oncogene Research, Cambridge, MA, U.S.A.) and 0.01 ng of activated MMP-9/MMP-2 (Oncogene Research) were used as the MMP standards. To quantify the protein ex pression, the gels were scanned using a densitometer (GS-700, Bio-Rad Laboratories, Richmond, CA, U.S.A.) and analyzed using Multi-Analyst 1.0.2 software (Bio-Rad). Recovery of pro-MMP-9 and pro-MMP-2 through the purification steps was estimated using this zymographic analysis.
Type IV collagenase activity assay
Type IV collagenase activity assay was performed using a commercially available kit (Chemicon International, Temecula, CA, U.S.A.). According to the manufacturer's protocol, 50 ILL of samples were incubated with fluorescein-5-isothiocyanate -labeled type IV collagen solution, first for 20 minutes at room temperature and then for 2 hours at 42°C in a water bath. Samples were then placed on ice for 5 minutes. Three hundred microliters of cold enzyme stop reagent/extraction solution were added to all samples which were then stored for 35 min utes on ice. Residual undigested collagen was precipitated by centrifugation (10 minutes at 12000 x g). A standard curve was made using MMP-9 standard solution provided by the manu facturer. Proteolytic activity of the injured samples was mea sured with or without ethylene diaminetetraacetic acid (0.5 mmollL), which is known to inhibit MMPs. Finally, fluores cence intensity of sample supernatants was measured with a fluorometer (Molecular Devices, Sunnyvale, CA, U.S.A.) at 538 nmI485 nrn.
Immunohistochemistry of gelatinase B
Anesthetized animals were perfused with 10 U/mL heparin and subsequently with 4% formaldehyde in 0.1 mollL phos phate-buffered saline (pH 7.4) 24 hours after CI. The brains were removed, postfixed for 36 hours in 4% formaldehyde, sectioned at 75 mm on a vibratome, and processed for immu nohistochemistry. The sections were incubated with a blocking solution containing 20% normal goat serum (Vector, Burlin game, CA, U.S.A.) and reacted with antihuman MMP-9 poly clonal antibody (Anawa, Wangen, Switzerland) at a dilution of 1: 100. Immunohistochemistry was performed using the avidin biotin technique (Vector), and then the nuclei were counter stained with methyl green solution for 10 minutes. As a nega tive control, sections were incubated without primary antibod ies. For histologic assessment, alternate slices from each brain section were stained with cresyl violet.
Western blot analysis
The supernatants from brain homogenates were prepared as U.S.A.) and developed as above, MMP-9 Western blotting was performed as previously described (Gasche et a!., 1999) . The affinity-purified MMP samples were mixed with the same vol ume of 2 x SDS sample buffer (Novex) and boiled for 5 min utes. The samples were then loaded onto 8% Tris-glycine gels and transferred to polyvinylidene diflouride membranes. The primary antibodies were diluted 1: 1000 for rabbit polyclonal antibody against human MMP-9 (Anawa, no. 5980-0907) and
incubated with the membranes. The membranes were further incubated with horseradish peroxidase-conjugated antirabbit immunoglobulin G (Boehringer Mannheim) and developed as above.
Statistical analysis
Data are presented as the mean ± standard deviation. Statis tical comparisons were evaluated by ANDV A followed by un paired Student's t test using StatView software, version 4.5 (Abacus Concepts, Berkeley, CA, U.S.A.). P < 0.05 was con sidered to be statistically significant.
RESULTS
Early induction and activation of pro-gelatinase B
is followed by delayed activation of gelatinase A after cold injury in mice
The expressions of pro-and activated MMPs were first examined by gelatin zymography (F ig. I) . In order to detect pro-and activated MMP-9 and MMP-2 with better sensitivity, the gelatinases were purified up to 21 7.5 ± 35.0 -fold ( n = 5) and concentrated 5 times from brain homogenates with 85% to 90 % of MMP recovery, using their selective affinity to gelatin sepharose after centrifugation, as described in Materials and Methods ( Fig. l A) . Pro-MMP-9 was increased 2 hours after injury with a molecular weight of 96 kDa and was maximized at 12 hours in wild-type mice (F ig. l B, lanes 1 to 8).
Activated MMP-9 with a molecular weight of 88 kDa app eared 4 hours after injury and was also maximized at 12 hours (F ig. IB , lanes 3 to 6), whereas it was not detected in the control (F ig. 1B, lane 1) and contralateral hemispheres ( data not shown). A slight induction of pro MMP-2 with a molecular weight of 72 kDa was observed from 6 hours and was further increased at 3 days (F ig. l B). The MMP-2 activated form was first observed from 24 hours after injury with a molecular weight of 64 kDa and was maximized 7 days after CI (F ig. 1B, lanes 6 to 8 ). Figure 2 demonstrates the quantitative analysis of z ymographic measurements of pro-MMP-9 ( Fig. 2 , up p er graph) and pro-MMP-2 (F ig. 2, lower gra ph). Induc tion of pro-MMP-9 became significant at 12 hours and 3 days when pro-MMP-9 was 10 0 .9-fold and 73 .6-fold, respectively, compared with the control (F ig. 2, upper graph). Induction of pro-MMP-2 was significant 6 hours,
Quantitative analysis of gelatin zymography of mice brain extracts after cold injury (CI). Graphs show quantitative analysis of zymograms from three independent studies. Optical density values among three zymograms were adjusted using standard human pro-gelatinase B (MMP-9) and pro-gelatinase A (MMP-2) (Oncogene Research). Statistical analysis showed a significant increase at 12 and 72 hours in pro-MMP-9 expression and at 6, 12, 72, 168 hours in pro-MMP-9 expression (*P < 0.05, **P < 0.001, n = 3, versus normal control; upper panel). A mild increase in pro-MMP-2 reached significance 3 days after CI (lower panel). 12 hours, 3 days, and 7 days after CI. Three days after CI, pro-MMP-2 induction was maximized and was 3.80 -fold compared with the control (F ig. 2, lower graph), which was milder than pro-MMP-9. In order to further evaluate the actual proteolytic activity of the extracted samples used for zymographic analysis, we performed an enzy matic activity assay using fluorescein-5-isothiocyanate labeled type IV collagen as substrates of MMP-9 and MMP-2. We detected increased activity in digestion of type IV collagen at 1 2 hours ( 95.8 ± 32.6 mU/mL, mean ± SD , n = 3) and 7 days (5 3.9 ± 61.2 mU/mL, n = 3) compared with the normal control ( 1. 5 ± 0. 5 mU/mL, n = 3). These activities were inhibited by adding 0. 5 mmollL ethylene diaminetetraacetic acid, confirming the involvement of MMPs in the activities observed ( data not shown). Because no activated form of MMP-9 was observed at 7 days, collagenase activity detected at 7 days was considered to mainly reflect MMP-2 activity. To examine the anatomic distribution of induced MMP-9, we performed immunohistochemical staining 24 hours after CI (F ig. 3). A strong MMP-9 immunore activity was observed mainly in the perilesional area (F ig. 3A, area 1, and 3C), but not in the core of the lesion or control brain (F ig. 3A, areas k and m, and 3B). There was no immunoreactivity in the specimens that were treated without a primary antibody ( data not shown). In our previous study, we confirmed this antibody's immu noreactivity to mouse pro-MMP-9 and activated MMP-9 by Western blotting ( Gasche et aI., 1999) . In the present study, Western blot analysis of MMP-9 further con firmed the same immunoreactivity of the antibody against mouse MMP-9 induced after brain edema ( data not shown). MMP-2, its expression was also examined by Western blot analysis (F ig. 4B, upper panel). MT -MMP-I, which appeared as a characteristic band of 66 kDa in the normal control, was slightly induced from 4 hours, was maxi mized at 12 hours, and gradually decreased until 7 days after CI (F ig. 4B, upper panel).
Induction and activation of matrix metalloproteinases were reduced by superoxide
dismutase-l overexpression in mice
To further investigate the molecular mechanisms of MMPs after CI, we examined the effect of SOD-I on MMP induction and activation. We used SOD-I trans genic mice that overexpress SOD-I 2.9-fold in the brain cortex compared with nontransgenic mice, as previously J Cereb Blood Flow Metab, Vol. 20, No.1, 2000 described ( Chan et aI., 1991) , Figure S demonstrates ex pression of pro-MMP-9 in both wild-type and transgenic mice. There were no differences in pro-MMP-9 basal expression between the transgenic and wild-types (F ig. SA, lanes I and 2). Pro-MMP-9 induction in the injured area was apparently reduced in SOD-l transgenic mice compared with that in wild-type mice from 4 hours after CI (F ig. SA). A quantitative analysis showed significant reduction of pro-MMP-9 ; this expression in transgenic mice was approximately 28.8% ( n = 7, P = 0. 002 ) and 47.S% ( n = 6, P = O.OS) of wild-type mice at 4 hours and 12 hours, respectively (F ig. SB, 4 and 12), whereas no difference was seen in pro-MMP-9 expression in con trol animals (F ig. SB). The effect of SOD-I on MMP-2 induction and activation 7 days after CI is shown in TIMP-1 was evident as 30-kOa characteristic bands in both the normal control (lane 1) and the injured brain (lanes 2 to 6). TIMP-2 was evident as 21.5-kOa characteristic bands in both the normal control (lane 1) and the injured brain (lanes 2 to 6). Rep resentative samples showed TIMP-1 and TIMP-2 were not regu lated or induced by CI. (B) Top, Western blot analysis of mem brane type-1 matrix metalloproteinase (MT -MM P-1 ) using brain homogenates extracted from the normal control brain (lane 1, Cl) and the injured regions (lanes 2 to 6). MT-MMP-1 was evident as 66-kOa characteristic bands, which showed a mild increase 4 to 72 hours after cold injury (CI). Bottom, The l3-actin Western blot analysis of the same samples for TIMP-1, TIMP-2, and MT MMP-1 shown as an internal control.
6 . Induction of pro-MMP-2 was also significantly re duced by SOD-l overexpression ( Figs. 6A and 6B, pro MMP-2, n = 3, P < 0. 0 5). Furthermore, activation of MMP-2 observed 7 days after injury in wild-type mice was not detected in SOD-l -overexpressing transgenic mi ce ( Figs. 6A and 6B , MMP-2, n = 3, P < 0. 0 5). No difference was seen in pro-MMP-9 expression in control animals (F ig. 6B, CL).
DISCUSSION
The present study provides the first evidence that MMP-9 and MMP-2 was induced independently after CI, which is known as a model for vasogenic brain edema and t rauma ( Chan et al., 1991) and that this induction was prevented by the overexpression of the antioxidant enzyme SOD-I. We used gelatin affinity gel to concen trate and purify MMP-9 and MMP-2 ( Zhang and Gottschall, 199 7) , which enabled us to detect pro-and activated MMPs with better sensitivity ( Fig. l A) . Early induction of pro-MMPs was maximized at 12 hours and was more prominent in pro-MMP-9 (l 0 0. 9-fold com pared with normal control) than in pro-MMP-2 ( 2.5-fold compared with normal control), whereas activation of MMP-9 was observed at 2 hours until 24 hours, with its peak at 12 hours (F igs. 1 and 2). A secondary mild in duction of pro-MMP-2 was maximized at 3 days and lasted until 7 days, with a strong, clear band of activated MMP-2 (F igs. 1 and 2).
To investigate the contribution of ROS to the molecu lar mechanisms of MMP induction and activation after CI, we examined the effect of SOD-l overexpression using transgenic mice, which was reported to cause a significant reduction in vasogenic edema after CI ( Chan Optical density values between zymograms were adjusted using standard human pro-MMP-9 and pro-MMP-2 (Oncogene Research). Statistical analysis showed a significant reduction 4 hours (** P < 0.01, n = 7; pro-MMP-9 expression in wild-type versus transgenic mice) and 12 hours (* P < 0.05, n = 6) after CI, whereas no difference was seen in control animals (P = 0.98, n = 5). showing MMP-2 activation at 7 days after cold injury (CI). MMP-2 activation that occurred in wild-type (Wt) mice (lanes 3, 5, 7; [I]) was reduced in mice that overexpressed SOO-1 (lanes 9, 11, 13; S001 transgenic [Tg], injury [I]) in the injured region 7 days after CI. Three independent samples from both wild-type and trans genic mice are displayed. Controls were obtained from the nor mal cortex (lanes 1 and 2, control [Cll) . Pro-MMP-2 on the con tralateral side was riot induced and activated by the injury in either wild-type or transgenic mice (lanes 2, 4, 6, 8, 10, 12; Wt and SOO-1 Tg, control [C] ). lane 1 shows 0. 1 ng of human pro-gelatinase B (MMP-9) and pro-MMP-2 (Oncogene Re search). (8) Quantitative analysis of pro-and activated MMP-2 from zymography. Graphs represent mean values (± SO) of pro MMP-2 optical density in control animals (Cl) and in mice 7 days after CI (proMMP-2) and activated MMP-2 in mice 7 days after CI (actMMP-2). Comparisons of pro-MMP-9 expression between wild-type (hatched boxes) and transgenic mice (white boxes) at the same time points were performed in one gel. Statistical analy sis showed a significant reduction in both pro-MMP-2 expression (*P < 0.05, n = 3; pro-MMP-9 expression in wild-type versus transgenic mice) and activated MMP-2 expression (*P < 0.05, n = 3) 7 days after CI, whereas no difference was seen in pro MMP-2 expression in control animals (P = 0.87, n = 3). et aI., 1991). The early induction of pro-MMP-9 at 4 and 12 hours after injury was significantly reduced by SOD-l overexpression (F ig. 5), and the activation of MMP-2 at 7 days was apparently inhibited by SOD-l overexpres sion (F ig. 6). These results suggest that SOD-l prevents the early induction of MMP-9 and could thereby reduce the subse quent vasogenic edema formation and infarc tion after CI ( Chan et aI., 1991) . The mechanism of this reduction of MMP-2 activation at 7 days by SOD-l is not clear. It is conceivable that the lesser amount of brain damage did re quire less MMP-2 activation in transgenic mice compared with wild-type animals. We do not rule out the possibility that MMP-2 in transgenic mice was activated earlier than the time point at which we ob served activation in the wild-type animals. Although fur ther examination is necessary to clarify this point, our data suggest the multiple involvement of ROS in the mechanism of MMP induction and activation. In fact, it has been suggested that ROS regulate the activity of MMPs in vitro ( Rajagopalan et aI., 1 996) . Previous studies using the same model have provided evidence of the early opening of the BBB within 30 minutes ( Murakami et aI., 1999) , which lasts for 24 hours ( Chan et aI., 198 7, 1991) . This was demonstrated by extravasation of a serum albumin tracer, Evans blue, whereas water content in the injured hemisphere was maximized at 24 hours followed by formation of infarc tion. In our study, induction of MMP-9 appeared as early as 2 hours (l 9.8-fold compared with normal control) af ter injury and was maximized at 12 hours with mild induction of MMP-2 (F ig. 2), which preceded the peak of water content increase ( Murakami et aI., 1999) . Further more, significant attenuation of MMP-9 expression 4 and 12 hours after CI in SOD-l transgenic mice in the present study consistently resulted in the marked decrease of lesion volume in transgenic mice 24 hours after CI ( Chan et aI., 1991 ; Murakami et aI., 1999) . These results to gether suggest the possibility that the early induction and activation of MMPs may contribute to edema formation and lesion volume after CI. However, we do not com pletely rule out the possibility that other factors such as mechanical damage of endothelial cells by CI also played a role in BBB permeability as shown by Evans blue extravasation at the early time points.
Recently, MMP-9 was implicated in BBB disruption in a variety of central nervous system disorders ( Rosen berg et aI., 1996 ( Rosen berg et aI., , 1998 Paul et aI., 1998 ; Romanic et aI., 1998 ; Zhang et aI., 1998) . We have demonstrated the early induction and activation of MMP-9 after focal ce rebral ischemia, in which the early appearance of acti vated MMP-9 was consistent with the BBB opening ( Gasche et aI., 1999) . In fact, it was reported that the MMP inhibitor BB-I10 1 reduced the BBB opening after focal ischemia ( Rosenberg et aI., 1998) , which may also support the idea that activation of MMP-9 contributes to BBB dysfunction. The early appearance of activated MMP-9 shown in the present study may also suggest the role of MMP-9 in vasogenic edema formation after CI.
Further study using MMP inhibitors and/or MMP knock out mice would be necessary to address the role of MMPs in edema formation after CI. In contrast to MMP-9, little is known about MMP-2 induction ( Clark et aI., 1997) and, especially, MMP-2 activation by cleavage after brain insult as in this study (F igs. 1 and 6) . In the present study, a mild and biphasic pro-MMP-2 was induced: the early induction which was accompanied by a strong MMP-9 induction and the sec ondary induction which lasted 7 days after the injury. Furthermore, we observed characteristic activation of MM P-2 7 days after injury, when tissue remodeling is assumed to be taking place after the peak of the infarc tion. Therefore, this MMP-2 activity is assumed to con tribute to tissue remodeling of the lesion and is unlikely to be correla t ed with the BBB opening and edema for ma t ion. Moreover, the activated nature of 64 kDa of MMP -2 observed by zymographic analysis was sup ported by the presence of the digestion of type IV col lagen ( Results). MMP-2 induction and MT-MMP-l co localiza t ion in cerebral aneurysms was recently repor t ed, suggesting that activation of MMP-2 may contribute to vascular extracellular matrix remodeling in cerebral an eurysms ( Bruno et aI., 1998) . MT -MMP-I, which is ac tivated by processing of its 66-kDa proform to become active 60 -kDa MT -MMP-1, is known to cleave pro MMP-2 to become a biologically active form (T akino et aI., 1995) . Therefore, we sought to clarify the contribu tion of M T-MMP-1 to this MMP-2 activation observed 7 days after CI. Western blot analysis did not show a sig nificant change in MT -MMP-1 expression 7 days after CI (F ig. 4B). A slight induction of MT -MMP-l was ob served much earlier ( 4 to 24 hours) than the activation of pro-MMP-2 (F ig. 4B). Although the mechanisms of this MMP-2 activation remain unclear, it will be interesting to determine in future studies the anatomic distribution of M T-MMP-1 and MMP-2 by immunohistochemistry to evaluate the role of MT -MMP-1 in MMP-2 activation. Additionally, we cannot exclude the possibility of other unknown factors activating MMP-2 by cleavage. Further studies may be required to clarify this point.
Activation of MMPs is a complex process, which is tightly regulated by their natural inhibitors, TIMPs. The detection by zymography of activated MMPs, although indicative, does not reveal the actual proteolytic activity of the enzyme in vivo. Indeed, during the zymographic procedure, MMPs are separated from their respective TIMPs. In order to partially solve this problem and better define the balance between MMP-9 and its natural in hibitors TIMP-1 and TIMP-2, we detected the level of their expression by Western blotting under the same ex perimental conditions (F ig. 4A ). Unlike MMP-9 and MMP-2, TIMP-1 and TIMP-2 were not induced after CI. A recent study showed a significant increase of TIMP-1 mR NA after focal ischemia (W ang et aI., 1998), whereas its protein expression was not induced ( Romanic et aI., 1998 ; Gasche et aI., 1999) . Although, the mR NA expres sion after CI was not examined, it is possible that there is a discrepancy between mR NA and protein expression because of posttranscriptional regulation of the inhibitor.
The exact mechanisms involved in the independent induction and activation of MMP-9 and MMP-2 are not well defined. As for the MMP-9 cell population, it could be induced in a variety of cells in the central nervous system, not only endothelial cells (N guyen et aI., 1998) but also astrocytes , oligoden drocytes ( Uhm et aI., 1998) , microglia ( Gottschall et aI., 1995) , and neurons ( Backstrom et aI., 1996) . In the present s t udy, immunohistochemistry suggested the MMP-9 expression in the heterogeneous cell popUlations including neurons and astrocytes (F ig. 3C). A double staining of MMP immunohistochemistry with various cell markers will provide important information to con finn this issue. Because MMP-9 has an activator pro tein-I ( AP-1) binding site in its promoter region, it is conceivable t ha t the early induction of pro-MMP-9 is associated with the alteration of AP-I DN A-protein binding activity after CI. In fact, our preliminary study demonstrated that there was an early increase in AP-1 binding activity after CI, which was observed by elec trophoretic mobility shift assays ( unpublished data). A significan t increase in AP-1 binding activity was also reported in several studies of brain insults, such as trau matic brain injury ( Yang et aI., 1994 ) or ischemia ( Sal minen et aI., 1995), followed by an early induction of genes, such as c-fos and c-jun , which interact with the AP-I site ( An et aI., 199 3) . Those early genes are also sensitive t o ROS ( Pinkus et aI., 1996) . Therefore, it is also conceivable that overexpression of SOD-1 in trans genic mice may contribute to the reduction of AP-I bind ing activity, thereby preventing MMP-9 induction in the present study. Further examination of AP-I binding ac tivity after CI in transgenic mice will address this critical issue.
In conclusion, we have demonstrated the first evidence that MMP-9 and MMP-2 are induced independently after CI and that the early induction of MMP-9 is regulated by SOD-I, whereas that of MMP-2 is not. These results suggest that SOD-1 prevents the early induction of MMP-9, thereby reducing t he subsequent vasogenic edema formation and infarction after CI.
